FreeTheAI

STERIS to Acquire Xodus Medical in $2.1 Billion Deal

BullishMedium impact
STE$214.40 1.73%

STERIS plc (STE) has signed a definitive agreement to acquire Xodus Medical for $2.1 billion. Net of anticipated cash tax benefits valued at roughly $300 million, the effective purchase price is approximately $1.8 billion. The acquisition will be funded primarily through debt and includes contingent earnout payments of up to $150 million payable in 2028 based on financial performance.

The transaction adds Xodus Medical's operating room consumables portfolio to the company's product line, strengthening its recurring revenue base. For 2026, Xodus forecasts revenue of approximately $245 million and adjusted EBIT of around $135 million, reflecting an adjusted EBIT margin near 55%. Shares of STERIS rose 1.73% to $214.40 following the news.

Moving forward, investors will focus on debt levels and financing terms as leverage increases. Key factors to watch include regulatory approvals, progress toward the targeted close date of December 31, 2026, and updated details on cost synergies and earnings integration.

Key points

  • STERIS plc signed a deal to acquire Xodus Medical for $2.1 billion, or $1.8 billion net of tax benefits.
  • Xodus Medical expects 2026 revenue of roughly $245 million and adjusted EBIT of about $135 million.
  • The agreement features up to $150 million in earnout payouts in 2028 contingent on meeting targets.
  • The transaction is expected to close by December 31, 2026, subject to regulatory approvals.

Written by our AI from expert market sources across the web. It can contain mistakes: check the facts before acting on them. Write-ups powered by the free AI API at FreeTheAI.org

How we writeDisclaimer

Questions and answers

How much is STERIS paying to acquire Xodus Medical?

STERIS is paying $2.1 billion for Xodus Medical. Expected cash tax benefits of about $300 million bring the net price to roughly $1.8 billion, with up to $150 million in performance earnouts available in 2028.

When is the STERIS acquisition of Xodus Medical expected to close?

The transaction is scheduled to close by December 31, 2026, pending regulatory approvals and standard closing conditions.

What are Xodus Medical's projected earnings and revenue?

Xodus Medical anticipates revenue of approximately $245 million and adjusted EBIT of around $135 million in 2026.